BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Everolimus
1
Advancements in medical treatment for pancreatic neuroendocrine tumors: A beacon of hope
3/28/2024 12:17:56 PM | Browse: 320 | Download: 857
2
Pneumocystis jirovecii diagnosed by next-generation sequencing of bronchoscopic alveolar lavage fluid: A case report and review of literature
2/6/2023 6:38:44 AM | Browse: 419 | Download: 1327
3
Bone marrow metastatic neuroendocrine carcinoma with unknown primary site: A case report and review of the literature
10/21/2022 2:24:59 AM | Browse: 559 | Download: 1548
4
Current aspects of renal dysfunction after liver transplantation
1/21/2022 8:16:14 AM | Browse: 849 | Download: 1908
5
Acquired hepatocerebral degeneration in a metastatic neuroendocrine tumor long-term survivor - An update on neuroendocrine neoplasm’s treatment: A case report
5/20/2021 3:14:20 PM | Browse: 839 | Download: 2350
6
Safety and performance of the EverProTM everolimus-eluting coronary stent system with biodegradable polymer in a real-world scenario
12/17/2020 9:42:32 AM | Browse: 953 | Download: 2355
7
Current status of PI3K-mTOR inhibition in hormone-receptor positive, HER2-negative breast cancer
12/21/2018 1:32:15 AM | Browse: 1262 | Download: 1703
8
Introduction of everolimus in kidney transplant recipients at a late posttransplant stage
9/7/2018 6:15:25 AM | Browse: 1218 | Download: 2077
9
Use of everolimus in liver transplantation
8/18/2017 1:45:25 AM | Browse: 1410 | Download: 1970
10
Benefit of everolimus in treatment of an intrahepatic cholangiocarcinoma patient with a PIK3CA mutation
6/20/2017 12:12:53 PM | Browse: 1288 | Download: 2404
11
Translating new data to the daily practice in second line treatment of renal cell carcinoma: The role of tumor growth rate
4/7/2017 8:24:12 AM | Browse: 1352 | Download: 2049
12
Growth hormone abolishes the negative effects of everolimus on intestinal wound healing
4/29/2016 4:50:00 PM | Browse: 1669 | Download: 3186
13
Sequential treatment in disseminated well- and intermediate-differentiated pancreatic neuroendocrine tumors: Common sense or low rationale?
4/7/2016 11:01:00 AM | Browse: 1343 | Download: 2326
14
Medical treatment for gastro-entero-pancreatic neuroendocrine tumours
3/30/2016 2:15:00 PM | Browse: 1533 | Download: 2170
15
Angiographic and volumetric effects of mammalian target of rapamycin inhibitors on angiomyolipomas in tuberous sclerosis
3/21/2016 8:54:00 AM | Browse: 1328 | Download: 2087
16
Immunosuppressive potency of mechanistic target of rapamycin inhibitors in solid-organ transplantation
3/18/2016 2:28:00 PM | Browse: 1573 | Download: 2465
17
Twelve-month efficacy and safety of the conversion to everolimus in maintenance heart transplant recipients
12/23/2015 8:26:00 AM | Browse: 1525 | Download: 2740
18
Combining cytochrome P-450 3A4 modulators and cyclosporine or everolimus in transplantation is successful
12/23/2015 8:26:00 AM | Browse: 1384 | Download: 3167
19
Excellent long term patient and renal allograft survival after ABO-incompatible kidney transplantation: Experience of one center
12/23/2015 8:26:00 AM | Browse: 1745 | Download: 3764
20
Neuroendocrine tumors resistant to mammalian target of rapamycin inhibitors: A difficult conversion from biology to the clinic
12/9/2015 6:37:00 PM | Browse: 1451 | Download: 2269
21
Mammalian target of rapamycin inhibition in hepatocellular carcinoma
12/2/2015 12:16:00 PM | Browse: 1415 | Download: 1873
22
Chemotherapy and target therapy for hepatocellular carcinoma: New advances and challenges
4/19/2015 5:46:00 PM | Browse: 1579 | Download: 2279
23
Overcoming endocrine resistance in metastatic breast cancer: Current evidence and future directions
12/11/2014 2:06:00 PM | Browse: 1381 | Download: 1912
24
Amenorrhea as a rare drug-related adverse event associated with everolimus for pancreatic neuroendocrine tumors
11/17/2014 3:13:00 PM | Browse: 1261 | Download: 1940
25
Hepatitis B reactivation related to everolimus
9/10/2014 3:18:00 PM | Browse: 1302 | Download: 936
26
Everolimus immunosuppression reduces the serum expression of fibrosis markers in liver transplant recipients
8/25/2014 9:54:00 AM | Browse: 1180 | Download: 1679
27
Multiple indications for everolimus after liver transplantation in current clinical practice
8/25/2014 9:54:00 AM | Browse: 1266 | Download: 1516